Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.0820
0.00 (0.00%)
May 18, 2026, 3:07 PM EST
Altamira Therapeutics Market Cap
Altamira Therapeutics has a market cap or net worth of $467.53 thousand as of May 19, 2026. Its market cap has decreased by -8.83% in one year.
Market Cap
467.53K
Enterprise Value
1.25M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 467.53K, a decrease of -99.73%. That is a compound annual growth rate of -39.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 467.53K | -11.56% |
| Dec 31, 2025 | 528.62K | 40.64% |
| Dec 31, 2024 | 375.87K | -72.84% |
| Dec 29, 2023 | 1.38M | -75.59% |
| Dec 30, 2022 | 5.67M | -78.93% |
| Dec 31, 2021 | 26.91M | -10.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exousia Pro | 716.02K |
| SQZ Biotechnologies Company | 707.79K |
| Aibotics | 483.69K |
| Regenerative Medical Technology Group | 463.02K |
| Helix BioMedix | 402.23K |
| Actavia Life Sciences | 385.91K |
| THC Farmaceuticals | 326.37K |
| Sorrento Therapeutics | 326.23K |